First Batch of EHang’s EH216-S Delivered to Xishan Tourism and Completed Debut Passenger-Carrying Flights in Taiyuan
July 29, 2024 06:09 ET
|
EHang Holdings Limited
GUANGZHOU, China, July 29, 2024 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading urban air mobility (“UAM”) technology platform company, today...
Enlight Announces Financial Close on Atrisco Energy Storage Project
July 29, 2024 06:01 ET
|
Enlight Renewable Energy Ltd.
The financing package for the energy storage portion of the project includes over $400 million of loans and tax equity arranged by HSBC and U.S. Bank Atrisco is one of Enlight’s flagship projects in...
Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
July 29, 2024 06:00 ET
|
Collegium Pharmaceutical, Inc.
– Adds Commercial Product Jornay PM®, Establishing Collegium’s Presence in Neurology (ADHD) – – H1’24 Jornay PM Prescriptions Grew 32% Year-over-Year – – Transaction Expected to...
Provident Financial Holdings Reports Fourth Quarter and Fiscal Year 2024 Results
July 29, 2024 06:00 ET
|
Provident Financial Holdings, Inc.
Provident Financial Holdings Reports Fourth Quarter and Fiscal Year 2024 Results.
Integra LifeSciences Reports Second Quarter 2024 Financial Results
July 29, 2024 06:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients
July 29, 2024 05:00 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients
DBV Technologies présente ses résultats financiers du premier semestre 2024 et fait le point sur l’évolution de ses activités
July 29, 2024 01:30 ET
|
DBV Technologies S.A.
Châtillon, France, 29 juillet (07:30 CEST), 2024 DBV Technologies présente ses résultats financiers du premier semestre 2024 et fait le point sur l’évolution de ses activités DBV Technologies...
DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
July 29, 2024 01:30 ET
|
DBV Technologies S.A.
Châtillon, France, July 29, 2024 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq...
Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference
July 28, 2024 17:00 ET
|
Anavex Life Sciences Corp.
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical...
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)
July 28, 2024 16:51 ET
|
Longeveron
Longeveron Phase 2a clinical results in Alzheimer's Disease selected for Featured Research oral presentation at Alzheimer’s Association International Conf